Question of the week - Week of 15-Mar-2017

A commercial vaccine based on a specific App serotype isolated in Europe ¿would it confer protection against the same serotype isolated in Asia?

Question of the week
Confirm

See a clue in the article Prevention of the disease caused by Actinobacillus pleuropneumoniae

Results

Correct answer

Strains belonging to a particular serotype are antigenically very similar throughout the world